Back to search

United States· US:66993-586_0318e892-0db1-4a82-a649-9e530a2d1d05

Fluticasone Propionate and Salmeterol

A corticosteroids, potent (group iii) product containing fluticasone propionate and salmeterol, registered in United States by Prasco Laboratories. The same ATC class is registered in 2 of our 19 countries.

In shortageATC D07ACOrange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFluticasone Propionate and SalmeterolATCD07ACREGISTER NO.US:66993-586_0318e892…PACKS LISTED1CHECKEDJune 3, 2026

Where it is registered

Fluticasone propionate and salmeterol is registered in 2 of 19 countries.

Countries holding a registration under ATC D07AC (corticosteroids, potent (group iii)), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose

Fluticasone propionate and salmeterol · ATC D07AC

2 / 19 countries

  • Italyprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
fluticasone propionate and salmeterol
Manufacturer
Prasco Laboratories
Country
United States (US)
ATC code
D07AC
ATC class
Corticosteroids, potent (group III)
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    6699358697
    1 INHALER in 1 CARTON (66993-586-97) / 60 POWDER in 1 INHALER

Regulatory notes

UNII (FDA substance ID)
O2GMZ0LF5W
FLUTICASONE PROPIONATE
RxCUI 50121
Orange Book
N021077
ABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Fluticasone Propionate; Salmeterol Xinafoate Powder

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ec246578-fc56-46ae-93d9-764a2869ec8a
GET /v1/drugs/ec246578-fc56-46ae-93d9-764a2869ec8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "O2GMZ0LF5W",
    "rxcui": "50121",
    "inchikey": "WMWTYOKRWGGJOA-CENSZEJFSA-N",
    "display_name": "FLUTICASONE PROPIONATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "RESPIRATORY (INHALATION)",
  "spl_meta": {
    "da4e897e-9be1-499a-8889-15398b30ef3b": {
      "match": "brand_token",
      "title": "FLUTICASONE PROPIONATE DISKUS (FLUTICASONE PROPIONATE) POWDER, METERED [A-S MEDICATION SOLUTIONS]",
      "spl_version": "1",
      "published_date": "2026-05-20"
    }
  },
  "productid": "66993-586_0318e892-0db1-4a82-a649-9e530a2d1d05",
  "productndc": "66993-586",
  "dosage_form": "POWDER",
  "orange_book": {
    "appl_no": "021077",
    "products": [
      {
        "rs": true,
        "rld": true,
        "te_code": "AB",
        "strength": "0.1MG/INH;EQ 0.05MG BASE/INH",
        "product_no": "001",
        "approval_date": "Aug 24, 2000"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AB",
        "strength": "0.25MG/INH;EQ 0.05MG BASE/INH",
        "product_no": "002",
        "approval_date": "Aug 24, 2000"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": "AB",
        "strength": "0.5MG/INH;EQ 0.05MG BASE/INH",
        "product_no": "003",
        "approval_date": "Aug 24, 2000"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE",
  "shortage_reason": "Fluticasone Propionate; Salmeterol Xinafoate Powder",
  "shortage_status": "current",
  "proprietary_name": "Fluticasone Propionate and Salmeterol",
  "active_ingred_unit": "ug/1; ug/1",
  "application_number": "NDA021077",
  "marketing_category": "NDA AUTHORIZED GENERIC",
  "nonproprietary_name": "fluticasone propionate and salmeterol",
  "start_marketing_date": "20190208",
  "active_numerator_strength": "500; 50"
}

See everything about fluticasone propionate and salmeterol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.